Study: social performance scale may forecast schizophrenia treatment success

NCT ID NCT07445217

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a scale that measures personal and social performance can predict symptom improvement in people with schizophrenia. Over 700 participants taking paliperidone were followed for 12 weeks. Results showed that those with better social functioning scores were more likely to see a meaningful drop in symptom severity. The study helps doctors understand which patients might benefit most from treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FUNCTIONAL OUTCOMES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Calo Psychiatric Center

    Pingtung City, 925, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.